INTRODUCTION
Capping of mRNA entails three enzymatic reactions in which the 5′ triphosphate end of pre-mRNA is hydrolyzed to a 5′ diphosphate by RNA triphosphatase, then capped with GMP by RNA guanylyltransferase, and methylated by RNA (guanine-7) methyltransferase (1) . The budding yeast Saccharomyces cerevisiae encodes a three-component capping apparatus consisting of separate triphosphatase (Cet1p), guanylyltransferase (Ceg1p) and methyltransferase (Abd1p) gene products. Each of the cap-forming activities is essential for yeast cell growth (2) (3) (4) (5) (6) (7) .
The yeast RNA triphosphatase Cet1p forms a heteromeric complex with the yeast RNA guanylyltransferase Ceg1p (8) (9) (10) . The binding of Cet1p to Ceg1p serves two purposes. First, Cet1p-Ceg1p interaction stimulates guanylyltransferase activity by enhancing the affinity of Ceg1p for GTP and increasing the extent of formation of the Ceg1p-GMP reaction intermediate (9) . Second, the physical tethering of Cet1p to Ceg1p facilitates recruitment of the triphosphatase to the RNA polymerase II elongation complex. The yeast guanylyltransferase Ceg1p binds to the phosphorylated C-terminal domain (CTD) of the largest subunit of RNA polymerase II, whereas Cet1p by itself does not bind to the phosphorylated CTD (11) (12) (13) .
The 549-amino acid Cet1p protein consists of three domains: (i) a 230-amino acid N-terminal segment that is dispensable for catalysis in vitro and for Cet1p function in vivo; (ii) a proteasesensitive segment from residues 230 to 275 that is dispensable for catalysis, but essential for Cet1p function in vivo; and (iii) a catalytic domain from residues 275 to 539 (10) . A homodimeric quaternary structure for the biologically active fragment Cet1(231-549)p was suggested based on analysis of the purified recombinant enzyme by glycerol gradient sedimentation (10) . Cet1(231-549)p binds in vitro to Ceg1p to form a 7.1S triphosphatase-guanylyltransferase complex that is surmised to be a trimer consisting of two molecules of Cet1(231-549)p and one molecule of Ceg1p. The more extensively truncated protein Cet1(276-549)p, which cannot support cell growth, sediments as a monomer and does not interact with Ceg1p (10) . These results implicate the segment of Cet1p from residues 230 to 275 in both Cet1p homodimerization and binding to the guanylyltransferase. The interaction of Cet1p with Ceg1p does not require a functional triphosphatase active site in Cet1p, insofar as Cet1p-Ceg1p complex formation is unaffected by mutations in the catalytic domain that abrogate RNA triphosphatase activity (14) .
Two lines of genetic evidence indicate that the Cet1p-Ceg1p interaction is important in vivo. First, several temperaturesensitive ceg1 mutations are suppressed in an allele-specific manner by overexpression of CET1 (9, 13) . In turn, the temperature-sensitive cet1-(K250A-W251A) mutation can be suppressed by overexpression of CEG1 (10) . This cet1-ts mutation is located with the segment of Cet1p that is suspected to mediate guanylyltransferase-binding. Fifteen other cet1-ts alleles with missense changes mapping elsewhere in the protein were not suppressed by CEG1 overexpression (10) . Second, the in vivo function of Cet1(275-549)p, which does not bind to Ceg1p in vitro, is completely restored by fusion of Cet1(275-549)p to the guanylyltransferase domain of the mouse capping enzyme (10) . This result shows that the need for Ceg1p-binding by yeast RNA triphosphatase can by bypassed when the triphosphatase catalytic domain is delivered to the RNA polymerase II elongation complex by linkage in cis to the mammalian guanylyltransferase. 
MATERIALS AND METHODS

Guanylyltransferase expression and purification
The S.cerevisiae CEG1 gene was inserted into a customized T7-based expression plasmid (a derivative of pET16b) in such a way as to fuse the 459-amino acid Ceg1p polypeptide in frame to an N-terminal 29-amino acid leader peptide (MGSH-HHHHHHHHHSSGHIEGRHSRRASVH) containing 10 consecutive histidine codons (His-tag) and a serine-phosphorylation site (RRASV) for protein kinase A. Recombinant Ceg1p was expressed in Escherichia coli BL21(DE3) and purified from a soluble bacterial lysate by nickel-agarose chromatography as described (10) . The C.albicans CGT1 gene was PCR-amplified from a genomic library clone using a sense primer designed to introduce an NdeI site at the translation start codon and an antisense primer that introduced a BamHI site immediately 3′ of the stop codon. The PCR product was digested with NdeI and BamHI and then inserted into yeast expression plasmid pYN132 to yield plasmid pYN-Cgt1. The CGT1 gene was excised from pYN-Cgt1 with NdeI and BamHI and then inserted into the T7-based expression vector pET16b so as to fuse the 449-amino acid Cgt1p polypeptide to a Nterminal 21-amino acid leader peptide containing the His-tag. Recombinant Cgt1p was expressed in E.coli BL21(DE3) and purified from a soluble bacterial lysate by nickel-agarose chromatography. The nickel-agarose preparations of Cet1p and Cgt1p were dialyzed against buffer containing 50 mM TrisHCl (pH 8.0), 50 mM NaCl, 2 mM DTT, 10% glycerol, 0.05% Triton X-100 and then stored at -80°C. Recombinant mouse guanylyltransferase Mce1(211-597)p was purified as described (15) . Protein concentrations were determined using the Bio-Rad dye binding reagent with bovine serum albumin as the standard.
Cet1 peptides
Peptides composed of Cet1p residues 232-265, 239-265 or 232-259 were synthesized in the Sloan-Kettering Microchemistry Core Laboratory on a Perkin-Elmer Biosystems 431A automated peptide synthesizer using standard Fmoc chemistry. Addition of biotin to the N-terminal amino group of the peptide was performed using reagents purchased from AnaSpec (San Jose, CA) according to the vendor's instructions. The peptides were purified on a preparative scale by reverse phase HPLC and the purity of the material was confirmed by analytic scale reverse phase HPLC as described (16) . The molecular weight of each peptide was analyzed by MALDI-TOF mass spectrometry. The measured masses were in agreement with the calculated theoretical masses within the limits of calibration of the instrument. The lyophilized peptides were dissolved in TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) and stored at 4°C.
The UV absorbance profiles of the Cet1 peptides revealed a large peak at <220 nM and a minor peak at 274-280 nM (the latter being attributable to tyrosine and tryptophan in the peptides). The molar concentrations of the peptides were calculated from the absorbance at 274 nM using the extinction coefficients of 1.4 × 10 3 M -1 for free tyrosine and 5.6 × 10 3 M -1 for free tryptophan.
Peptide-affinity chromatography
The biotinylated Cet1 peptides (1 nmol) were adsorbed to 0.6 mg of streptavidin coated magnetic beads (Dynabeads M280 streptavidin; Dynal) in 50 µl of binding buffer (25 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM DTT, 5% glycerol, 0.03% Triton X-100). The Dynabeads have a binding capacity of 650-900 pmol of free biotin per mg according to the manufacturers specifications; hence the amount of biotinylated Cet1 peptide was sufficient to saturate the bead-bound streptavidin. After incubation for 30 min on ice, the beads were concentrated using a horseshoe magnet and then washed three times with 0.5 ml of binding buffer to remove any unbound peptide.
Affinity chromatography was performed by mixing 4 µg of guanylyltransferase with 0.6 mg of Cet1 peptide beads (estimated to contain 390-540 pmol of peptide) in 50 µl of binding buffer. After incubation for 20-30 min on ice, the beads were concentrated by microcentrifugation for 15 s and then held in place with a magnet as the supernatant was withdrawn. The beads were resuspended in 0.5 ml of binding buffer and subjected to two cycles of concentration and washing. After the third wash, the beads were resuspended in 50 µl of binding buffer. Aliquots (20 µl) of the input protein sample, the unbound supernatant fraction and the bead bound fraction were mixed with 3 µl of SDS sample buffer (200 mM Tris-HCl, pH 6.8, 8% SDS, 140 nM β-mercaptoethanol, 40% glycerol), heated at 90°C for 3 min and then analyzed by electrophoresis through a 15% polyacrylamide gel containing 0.1% SDS. Polypeptides were visualized by staining the gel with Coomassie blue dye.
Guanylyltransferase assay
Guanylyltransferase activity was assayed by the formation of a covalent Ceg1-GMP intermediate (9) . Reaction mixtures (20 µl) containing 50 mM Tris-HCl, pH 8.0, 5 mM MgCl 2 , 0.17 µM [α-32 P]GTP, Ceg1p and Cet1 peptides as specified were incubated for 10 min at 37°C. The reaction was halted by addition of SDS to 1% final concentration. The samples were analyzed by SDS-PAGE. Transfer of labeled GMP to Ceg1p was visualized by autoradiography of the dried gel and quantitated by scanning the gel with a FUJIX BAS2500 phosphorimager.
Mutagenesis of yeast RNA triphosphatase
Alanine-cluster mutations were introduced into the CET1(201-549) gene by PCR as described (7, 10) . The mutated genes were inserted into the yeast CEN TRP1 plasmid pCET1-5′3′, where expression of the inserted gene is under the control of the natural CET1 promoter. The inserts were sequenced completely to exclude the acquisition of unwanted mutations during amplification and cloning. The W247A-Q249A and K250A-W251A genes were excised from their respective pCET1-5′3′ plasmids with NdeI and BamHI and inserted into the yeast expression vector pYN132 (CEN TRP1).
In this vector, expression of CET1(201-549) is driven by the strong constitutive yeast TPI1 promoter. The in vivo activity of the mutated CET1 alleles was tested by plasmid shuffle as described (9) . Yeast strain YBS20 (trp1 ura3 leu2 cet1::LEU2 p360-Cet1[CEN URA3 CET1]) was transformed with CEN TRP1 plasmids containing the wild-type and mutant alleles of CET1 . A control transformation was performed using the TRP1 vector. Trp+ isolates were selected and then streaked on agar plates containing 0.75 mg/ml of 5-fluoroorotic acid (5-FOA). Growth was scored after 7 days of incubation at 25, 30 and 37°C. Lethal mutants were those that failed to form colonies on 5-FOA at any temperature.
NdeI-BamHI fragments encoding mutated versions of Cet1(201-549)p were excised from the respective pCET1-5′3′ plasmids and inserted into pET16b. Wild-type Cet1(201-549)p and the W247A-Q249A mutant were expressed in E.coli BL21(DE3) at 37°C by IPTG-induction for 3 h. The K250-W251A mutant was expressed at 17°C by IPTG-induction for 20 h in the presence of 2% ethanol (14) . The proteins were purified from soluble bacterial lysates by nickel-agarose chromatography as described (7, 14) . The 0.2 M imidazole eluate fractions containing Cet1(201-549)p were dialyzed against 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 2 mM DTT, 10% glycerol, 0.05% Triton X-100 and then stored at -80°C.
Triphosphatase reaction mixtures (10 µl) containing 50 mM Tris-HCl (pH 7.5), 5 mM DTT, 2 mM MnCl 2 , 1 mM [γ-32 P]ATP and Cet1(201-549)p as specified were incubated for 15 min at 30°C. The reactions were quenched by adding 2.5 µl of 5 M formic acid. An aliquot (2.5 µl) of the mixture was applied to a polyethyleneimine-cellulose TLC plate, which was developed with 0.5 M LiCl and 1 M formic acid. The release of 32 Pi from [γ-32 P]ATP was quantitated by scanning the TLC plate with a phosphorimager.
Proteolytic footprinting of kinase-tagged Ceg1p
Ceg1p containing an N-terminal kinase tag was 32 P end-labeled using protein kinase A, which specifically phosphorylates the serine in the RRASV sequence of the N-terminal tag. Kinase reaction mixtures (100 µl) containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 0.2 mM [γ-32 P]ATP, 50 µg of Ceg1p and 5 U of protein kinase A (38 kDa catalytic subunit; New England Biolabs) were incubated for 5 min at 30°C. The mixture was adjusted to 50 mM EDTA and placed on ice. The labeled Ceg1p was resolved from free ATP by gel filtration of the sample through a 1-ml column of Sephadex G-50 at 4°C. The radiochemical purity of the 32 P-Ceg1p eluting in the void volume was confirmed by SDS-PAGE. The concentration of 32 P-Ceg1p was calculated from the signal intensity of the 32 PCeg1p protein and the specific activity of the ATP substrate used in the kinase reaction.
Footprinting reactions were performed as follows. Reaction mixtures (15 µl) containing 50 mM Tris-HCl (pH 8.0), 0.5 µg of 32 P-Ceg1p, 4 µg of either Cet1(201-549)p, Ceg1p or bovine serum albumin, and 0, 1, 5 or 10 ng of trypsin were incubated for 15 min at 22°C. The reaction was quenched by the addition of SDS sample buffer and the digests were analyzed by electrophoresis through a 15% polyacrylamide gel containing 0.1% SDS. 32 P-labeled tryptic fragments were visualized by autoradiography.
RESULTS
A synthetic peptide, Cet1(232-265), binds to Ceg1p and stimulates guanylyltransferase activity
Overlapping segments of Cet1p from residues 205 to 265 and 230 to 275 have been implicated in Ceg1p-binding using a variety of biochemical and genetic assays (10, 13) . To better understand the structural basis for Cet1p-Ceg1p interaction and the attendant stimulation of guanylyltransferase activity, we prepared a synthetic peptide ligand containing the 34-amino acid segment from Cet1p residues 232-265 (Fig. 1 ). An N-terminal biotin was added during chemical synthesis so that the peptide could be linked to streptavidin beads for affinity chromatography purposes. Peptide-containing beads and control streptavidin beads lacking peptide were then incubated with purified recombinant yeast guanylyltransferase Ceg1p (guanylyltransferase concentration 1.4 µM) in buffer containing 50 mM NaCl. The beads were recovered by centrifugation and held in place with a magnet while the supernatant containing free guanylyltransferase was withdrawn. The beads were washed with buffer containing 50 mM NaCl. The beadbound material was eluted from the beads with 1% SDS. The input guanylyltransferase protein (L) and the free (F) and beadbound (B) fractions were then analyzed by SDS-PAGE. The salient finding was that the Ceg1p bound nearly quantitatively to beads containing the Cet1(232-265) peptide, but not at all to streptavidin-alone control beads (Fig. 1A) or to beads containing a biotinylated 28mer peptide composed of four tandem copies of the CTD heptamer YSPTSPS (not shown). Note that the streptavidin polypeptide was stripped off the beads by 1% SDS and recovered in the bound eluate fraction (Fig. 1A) . This experiment shows that a defined synthetic peptide can be used to study the Cet1p-Ceg1p interaction and that the Cet1p segment from 232 to 265 suffices for binding to the yeast guanylyltransferase.
Previously, we showed that the binding of full-length Cet1p or Cet1(201-549)p to Ceg1p stimulates the guanylyltransferase activity of Ceg1p (9). Here we tested the effects of the Cet1(232-265) peptide on guanylyltransferase activity. Ceg1p was incubated for 15 min on ice with various concentrations of the peptide and aliquots of the mixtures were assayed for enzyme-GMP complex formation. Ceg1p-GMP formation was stimulated~11-fold by 50 nM peptide (Fig. 1B) . The foldstimulation was proportional to peptide concentration in the range 12-50 nM and plateaued at 50-100 nM. Maximal effect was attained at an~2:1 molar ratio of peptide to guanylyltransferase. We conclude that binding of Cet1p to Ceg1p and stimulation of guanylyltransferase activity are mediated by the same small peptide domain.
Effects of mutations within the Ceg1p-binding domain on Cet1p function in vivo
The sequence of the guanylyltransferase-binding peptide of S.cerevisiae RNA triphosphatase (amino acids 232-265) is conserved in the RNA triphosphatase of C.albicans ( Fig. 2A) . Previously, we reported an analysis of the effects of several alanine cluster mutations within this conserved region on Cet1p function in vivo (10) . Yeast cells expressing CET1(201-549) alleles K237A-P238A, K240A-Y241A and P245A-I246A grew as well as wild-type CET1(201-549) cells at all temperatures tested (the residues mutated are denoted by + above the Cet1p sequence in Fig. 2A) , whereas K250A-W251A cells displayed a temperature-sensitive (ts) growth phenotype (∆ in Fig. 2A ) that was suppressed by overexpression of CEG1 (10). We have now extended the alanine-cluster mutagenesis of the guanylyltransferase-binding domain to three other pairs of amino acids that are conserved in Cet1p and CaCet1p. The mutated residues are denoted by dots in Figure 2A . The mutant genes W247A-Q249A, N262A-V263A and K264A-D265A were cloned into a CEN TRP1 vector under the control of the CET1 promoter and then tested by plasmid shuffle for complementation of a cet1∆ strain. The N262A-V263A and K264A-D265A mutants were viable after selection on 5-FOA at 25, 30 or 37°C. N262A-V263A and K264A-D265A cells grew as well as wild-type cells on rich medium (YPD) at 25, 30 and 37°C. In contrast, the W247A-Q249A cells failed to give rise to FOAresistant colonies at all temperatures tested (25, 30 and 37°C); thus the W247A-Q249A change was lethal.
Some lethal mutations of CET1 can be suppressed by expression of the mutant allele under the control of the strong constitutive TPI1 promoter instead of the natural CET1 promoter (10). We found that CET1(W247A-Q249A) was still lethal at all temperatures tested (16, 25, 30 and 37°C) when its expression was driven by the TPI1 promoter. The TPI1-CET1(K250A-W251A) mutant was still temperature-sensitive, i.e. TPI1-CET1(K250A-W251A) cells grew at 25 and 30°C, but not at 37°C. The in vivo mutational effects point toward the conserved peptide WAQKW as a key constituent of the guanylyltransferase-binding site on yeast RNA triphosphatase.
In order to address whether mutations within the WAQKW motif might affect the catalytic activity of Cet1(201-549)p, the wild-type, W247A-Q249A and K250A-W251A proteins were expressed in bacteria as His-tagged fusions and purified from soluble lysates by nickel-agarose column chromatography (Fig. 2B) . Triphosphatase activity was determined by assaying manganese-dependent ATP hydrolysis as a function of input enzyme. The specific activities of W247A-Q249A and K250A-W251A were comparable to that of wild-type Cet1(201-549)p (Fig. 2B) . Thus, the in vivo phenotypes are not simply attributable to a catalytic defect. Moreover, an analysis of the native size of the W247A-Q249A and K250A-W251A proteins by glycerol gradient sedimentation indicated that the mutant proteins sedimented as homodimers, as did the wild-type Cet1(201-549)p (data not shown).
Effect of peptide deletions and mutations on guanylyltransferase-binding in vitro
Having validated the concept of using a synthetic peptide to study Cet1p-Ceg1p interactions, we sought to better define the guanylyltransferase-binding site by testing truncated and mutated Cet1 peptides as affinity ligands for Ceg1p. Biotinylated peptides composed of Cet1p amino acids 239-265 or 232-259 bound Ceg1p (Fig. 3A) and stimulated the guanylyltransferase activity of Ceg1p (Fig. 3B) , implying that the Ceg1p-binding epitope is situated within the overlapping 21-amino acid segment from 239 to 259. To address whether the WAQKW motif is involved in Ceg1p-binding, we introduced four alanines in lieu of Trp247, Gln249, Lys250 and Trp251 in the context of the 34mer Cet1(232-265) peptide. The instructive finding was that the 4× Ala cluster mutation abrogated both Ceg1p-binding and stimulation of guanylyltransferase activity (Fig. 3) .
The conserved triphosphatase peptide binds to C.albicans RNA guanylyltransferase
The C.albicans RNA triphosphatase (CaCet1p) and RNA guanylyltransferase (Cgt1p) are structurally similar to the S.cerevisiae Cet1p and Ceg1p enzymes. Moreover, S.cerevisiae cet1∆ and ceg1∆ null mutations can be complemented by CaCET1 and CGT1, respectively (17, 18) . To determine if the domain mediating the triphosphatase-guanylyltransferase interaction in S.cerevisiae is conserved functionally in other fungal capping systems, we evaluated the yeast triphosphatase peptides as ligands for the C.albicans guanylyltransferase. Cgt1p was expressed in bacteria as a His-tagged fusion protein and purified from soluble extracts by nickel-agarose chromatography. The enzyme preparation was nearly homogeneous with respect to the 54-kDa His-Cgt1p polypeptide (Fig. 4A , lane L) and the enzyme was catalytically active in transguanylylation (not shown). We found that Cgt1p was bound nearly quantitatively to beads containing the 34mer Cet1(232-265) peptide, but not at all to beads containing to the 34mer peptide with a 4× Ala mutation in the WAQKW motif (Fig. 4A) . Cgt1p, like Ceg1p, also bound to the truncated peptides Cet1(239-265) and Cet1(232-259). We conclude that the guanylyltransferase-binding domain of S.cerevisiae RNA triphosphatase (amino acids 239-259) is conserved in other fungi and we infer that the target site on the guanylyltransferase for Cet1p peptide-binding is also likely to be conserved among fungal capping enzymes. Peptide binding studies were performed with the guanylyltransferase domain of the mouse capping enzyme, Mce1p(211-597). Mce1p is a bifunctional 597-amino acid polypeptide composed of autonomous RNA triphosphatase (amino acids 1-210) and guanylyltransferase (amino acids 211-597) domains (15) . Mce1(211-597)p bound weakly to beads containing the guanylyltransferase-binding peptide of yeast RNA triphosphatase, and not at all to the beads alone or to beads containing the 4× Ala mutant peptide (Fig. 4B) . Most of the input mouse guanylyltransferase was recovered in the unbound fraction and very little was retained by the Cet1(232-265) peptide; this stands in contrast to the quantitative binding of the yeast guanylyltransferase to the Cet1(232-265) peptide when both capping enzymes were tested in parallel. The lowaffinity interaction of mouse guanylyltransferase with the yeast RNA triphosphatase peptide in vitro may explain the genetic observation that yeast cells containing a capping apparatus composed of Cet1p and Mce1(211-597)p are viable, but very slow growing (15) . We have since found that the slow growth phenotype of MCE1(211-597) cells can be suppressed by overexpression of CET1 (C.K. Ho, B. Schwer and S. Shuman, unpublished results).
Binding studies conducted using purified recombinant Chlorella virus guanylyltransferase, a monofunctional monomeric enzyme (19) , revealed a low extent of binding of the viral capping enzyme to beads containing the Cet1(232-265) peptide (data not shown), similar to what was observed in Figure 4B for the mouse guanylyltransferase.
Proteolytic footprinting of the Cet1p-binding site on Ceg1p
As a first step in defining the triphosphatase binding site on the yeast guanylyltransferase, we performed proteolytic footprinting of Ceg1p in the presence and absence of Cet1p. Recombinant guanylyltransferase containing a 5-amino acid N-terminal 'protein kinase tag' (RRASV) was 32 P end-labeled by in vitro reaction with protein kinase A (PKA) and [γ-32 P]ATP (20) . PKA specifically phosphorylates the serine in the tag. Control experiments verified that PKA did not phosphorylate recombinant Ceg1p that lacked the kinase tag (not shown). Aliquots (0.5 µg) of end-labeled Ceg1p were pre-incubated with 4 µg of unlabeled Cet1(201-549)p, 4 µg of unlabeled Ceg1p or 4 µg of bovine serum albumin (BSA) and the mixtures were digested with 1, 5 or 10 ng of trypsin. The reaction products were analyzed by SDS-PAGE and the labeled Nterminal fragments were detected by autoradiography (Fig. 5) . Digestion of the two 'control' mixtures of labeled guanylyltransferase with either cold Ceg1p or BSA by 1 ng of trypsin resulted in conversion of the input 54 kDa 32 P-Ceg1p into a prominent 32 P-labeled cleavage product of~35 kDa (denoted by the arrowhead in Fig. 5 ). Digestion with 5 and 10 ng of trypsin resulted in cleavage at secondary sites closer to the Nterminus to yield a predominant low molecular weight fragment and two minor species of intermediate mobility (Fig. 5) . The instructive finding was that pre-incubation of 32 P-Ceg1p with Cet1(201-549)p protected the primary tryptic site from proteolysis. This was evinced by (i) the complete resistance of 32 P-Ceg1p to digestion by 1 ng of trypsin, (ii) the persistence of a significant fraction of intact 32 P-Ceg1p at 5 ng of trypsin (this level of trypsin being sufficient to cleave all of the Ceg1p in the control mixtures to smaller fragments) and (iii) failure to accumulate significant amounts of the 35 kDa cleavage product even at 10 ng of trypsin (Fig. 5) . The protection by Cet1(201-549)p was selective for the primary site, insofar as treatment with 5 and 10 ng of trypsin still resulted in the production of the prominent low molecular tryptic fragment and the minor fragment migrating just above it (Fig. 5) . It was reported previously that initial scission of Ceg1p by trypsin occurs at two closely-spaced sites, Arg304-Leu305 and Lys306-His307, to yield an N-terminal fragment of 35 kDa and a carboxyl fragment of 20 kDa (1). The simplest interpretation of the present results is that the Cet1p-binding site on Ceg1p is located at or near Arg304 and Lys306, the primary tryptic sites protected from digestion in the presence of RNA triphosphatase, whereas secondary tryptic sites located close to the N-terminus (as yet unmapped) are not part of the Cet1p-Ceg1p interface. Consistent with this interpretation, we found that the 34mer Cet1(232-265) peptide was able to protect Ceg1p from proteolysis by trypsin, whereas the 4× Ala mutant peptide was not (data not shown).
DISCUSSION
We have co-localized the guanylyltransferase-binding and guanylyltransferase-stimulation functions of yeast RNA triphosphatase to a 21-amino acid peptide from residues 239 to 259. Within this peptide is a WAQKW motif that is implicated by alanine-cluster mutagenesis in Cet1p-Ceg1p interaction in vivo and in vitro. The correlation between the in vivo lethality of the W247A-Q249A mutation and the abrogation of guanylyltransferase-binding and stimulation by a WAQKWto-alanine cluster mutation of the Cet1(232-265) peptide provides the strongest evidence to date that the triphosphataseguanylyltransferase interaction is essential in yeast, i.e. because the alanine-cluster mutations in the WAQKW motif did not affect either the catalytic activity of yeast triphosphatase or its self-interaction to form a homodimer. Available data concerning yeast triphosphatase structure are consistent with the guanylyltransferase-binding epitope being located on the surface of the protein. Limited proteolysis of Cet1(201-549)p showed that the Tyr241-Arg242 peptide bond is highly sensitive to chymotryptic cleavage and that additional sites of accessibility to chymotrypsin and trypsin are clustered nearby at Lys256-Ala257, Leu258-Gln259 and Lys264-Asp265 (10). In contrast, the distal C-terminal portion of the protein is relatively protease-insensitive. We have recently crystallized a biologically active form of yeast RNA triphosphatase and determined its structure by X-ray diffraction (C. Lima, L. Wang and S. Shuman, submitted for publication). The structure reveals that the Cet1p segment from residues 241 to 259 is located on the protein surface and that the Trp247 side chain in the WAQKW motif is solventexposed (and thus in a position to interact directly with Ceg1p).
Our finding that the Cet1(232-265) peptide binds tightly to fungal guanylyltransferases and only weakly to the mammalian and Chlorella virus guanylyltransferases has interesting implications for the evolution of the capping apparatus. Fungal, metazoan and DNA virus guanylyltransferases share a catalytic mechanism of covalent nucleotidyl transfer and they have a common active site composed of six conserved motifs (21, 22) . The in vivo effects of mutations within the nucleotidyl transferase motifs of yeast Ceg1p are in accord with the molecular contacts between GTP and guanylyltransferase revealed in the crystal structure of the Chlorella virus capping enzyme (22, 23) . Thus, it is very likely that all cellular and DNA virusencoded guanylyltransferases share the same overall structural fold. Nonetheless, it is clear from sequence alignments that the conserved components of the guanylyltransferase catalytic site are embellished by intervening peptide segments that diverge in viruses, fungi and mammals.
It is surprising that a metazoan guanylyltransferase has any affinity for the guanylyltransferase-binding domain of yeast RNA triphosphatase, because the metazoan guanylyltransferase and triphosphatase activities are linked in cis within a single polypeptide and the metazoan RNA triphosphatase is structurally and mechanistically unrelated to the fungal RNA triphosphatase. Metazoan RNA triphosphatase is instead related to the superfamily of protein phosphatases that catalyzes phosphoryl transfer through a cysteinyl-phosphate intermediate (22, (24) (25) (26) . The vestigial low-affinity interaction of mouse guanylyltransferase with the Cet1 peptide suggests that guanylyltransferases evolved from an ancestral enzyme that did interact in trans with a triphosphatase, but that selection for such interaction was relaxed during the emergence of metazoa, because of a gene fusion event that linked the triphosphatase and guanylyltransferase domains in cis. We cannot at present discern any homolog of fungal RNA triphosphatase in genomic databases for metazoans, including the completed genome of the nematode Caenorhabditis elegans. The fusion of metazoan guanylyltransferase to a PPase-like RNA triphosphatase may have allowed for the loss of a Cet1p-like enzyme from the metazoan genome, or else have permitted the divergence of such a protein to a point that it serves a new function in metazoan species and is no longer discernible as Cet1p-like by available search programs.
Our proteolytic footprinting experiments provide the first physical evidence that yeast triphosphatase interacts with the C-terminal domain of yeast guanylyltransferase. The trypsinsensitive sites of Ceg1p that are shielded from proteolysis when Ceg1p is bound to Cet1p (denoted by arrowheads in Fig.  6 ) are located between nucleotidyl transferase motifs V and VI. An alignment of the sequences of the S.cerevisiae, C.albicans, mouse and Chlorella virus guanylyltransferases underscores the point that this intervening region is variable in length and poorly conserved, except for motif V c (Fig. 6 ). Segments present in the two fungal guanylyltransferases, which are absent from the mouse and Chlorella virus proteins, may well comprise the high-affinity Cet1p-binding surface of Ceg1p. Several ceg1-ts alleles containing missense mutations located between motifs V and VI in the C-terminal domain can be suppressed by overexpression of Cet1p (9, 13) . Several of the amino acids that are mutated in these ceg1-ts alleles are situated just proximal to the tryptic cleavage sites (denoted by ∆ in Fig. 6 ). Thus, biochemical and genetic experiments implicate the same segment of Ceg1p in triphosphatase-binding. The results presented here set the stage to define in molecular detail the triphosphatase-guanylyltransferase interface by crystallizing yeast guanylyltransferase bound to the Cet1(232-265) peptide. 
